FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
Enhancing Child Mental Health Services with Digital Interventions
Dementia Prevention in Latin America: A Focus on Modifiable Risk Factors
New Innovations in Elderly Healthcare: Latest PBAC Outcomes
Enhancing Skin Cancer Prevention in a Primary Care Setting
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Precision Medicine Competency Framework for the Medical Technology and Pharma...
Health equity insights for National Cancer Survivors Day
Balancing the scales: An inclusive framework for equity in Multi-Cancer Early...
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Patient Empowerment in Their Pockets: AI Chatbots in Healthcare
Enhancing Fairness in AI/ML Models for Healthcare Using Real-World Data
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...